Arcus Biosciences, Inc. RCUS NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score

55/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Arcus Biosciences, Inc. (RCUS), dont 17 achats et 31 ventes. Le total des achats d'initiés s'élève à $32.3M et le total des ventes d'initiés à $6.53M.

Les initiés notables ayant une activité récente comprennent Rosen Terry J, Jaen Juan C., Goeltz Ii Robert C.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — RCUS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-01-23	Rosen Terry J	Chief Executive Officer	Attribution de RSU	315,000	$22.13	$6.97M	315,000
2026-01-23	Jaen Juan C.	President	Attribution de RSU	126,000	$22.13	$2.79M	126,000
2026-01-23	Goeltz Ii Robert C.	Chief Financial Officer	Attribution de RSU	24,000	-	-	91,924
2026-01-23	Jarrett Jennifer	Chief Operating Officer	Attribution de RSU	126,000	$22.13	$2.79M	126,000
2026-01-23	Azoy Alexander	Chief Accounting Officer	Attribution de RSU	14,050	$22.13	$310.93K	14,050
2026-01-23	Tang Carolyn C.	General Counsel	Attribution de RSU	96,000	$22.13	$2.12M	96,000
2026-01-23	Markus Richard	Chief Medical Officer	Attribution de RSU	24,000	-	-	89,647
2026-01-08	Rosen Terry J	Chief Executive Officer	Don (Donné)	35,000	-	-	2,157,409
2026-01-05	Jaen Juan C.	President	Vente Informative	100	$23.20	$2.32K	922,240
2025-12-31	Goeltz Ii Robert C.	Chief Financial Officer	Vente Informative	6,552	$23.38	$153.19K	67,924
2025-12-30	Rosen Terry J	Chief Executive Officer	Don (Donné)	2,400	-	-	2,192,409
2025-12-18	Azoy Alexander	Chief Accounting Officer	Vente Informative	4,343	$22.25	$96.61K	18,531
2025-12-17	Rosen Terry J	Chief Executive Officer	Vente Informative	25,744	$22.16	$570.47K	2,194,809
2025-12-17	Jaen Juan C.	President	Vente Informative	9,983	$22.16	$221.22K	346,012
2025-12-17	Goeltz Ii Robert C.	Chief Financial Officer	Vente Informative	5,960	$22.16	$132.07K	74,476
2025-12-17	Jarrett Jennifer	Chief Operating Officer	Vente Informative	9,983	$22.16	$221.22K	193,024
2025-12-17	Azoy Alexander	Chief Accounting Officer	Vente Informative	2,113	$22.16	$46.82K	22,874
2025-12-17	Tang Carolyn C.	General Counsel	Vente Informative	6,810	$22.16	$150.91K	124,734
2025-12-17	Markus Richard	Chief Medical Officer	Vente Informative	4,494	$22.16	$99.58K	65,647
2025-12-16	Rosen Terry J	Chief Executive Officer	Vente Informative	28,947	$21.88	$633.48K	2,220,553
2025-12-16	Jaen Juan C.	President	Vente Informative	11,225	$21.88	$245.65K	355,995
2025-12-16	Goeltz Ii Robert C.	Chief Financial Officer	Vente Informative	6,702	$21.88	$146.67K	80,436
2025-12-16	Jarrett Jennifer	Chief Operating Officer	Vente Informative	11,225	$21.88	$245.65K	203,007
2025-12-16	Azoy Alexander	Chief Accounting Officer	Vente Informative	2,376	$21.88	$52K	24,987
2025-12-16	Tang Carolyn C.	General Counsel	Vente Informative	7,658	$21.88	$167.59K	131,544
2025-12-16	Markus Richard	Chief Medical Officer	Vente Informative	5,052	$21.88	$110.56K	70,141
2025-12-04	Jaen Juan C.	President	Vente Informative	82,997	$24.71	$2.05M	954,063
2025-11-26	Goeltz Ii Robert C.	Chief Financial Officer	Vente Informative	5,000	$25.00	$125K	87,138
2025-11-26	Azoy Alexander	Chief Accounting Officer	Exercice d'Options (Vente)	1,900	$13.33	$25.33K	9,500
2025-11-18	Jaen Juan C.	President	Vente Informative	5,050	$19.75	$99.74K	1,037,060
2025-11-17	Jaen Juan C.	President	Vente Informative	7,836	$20.71	$162.31K	1,042,110
2025-11-07	Jarrett Jennifer	Chief Operating Officer	Exercice d'Options (Vente)	50,291	$1.23	$61.74K	80,583
2025-10-30	Jaen Juan C.	President	Vente Informative	4,314	$20.32	$87.65K	1,087,060
2025-10-29	Jaen Juan C.	President	Vente Informative	800	$22.04	$17.64K	1,091,374
2025-10-28	Goeltz Ii Robert C.	Chief Financial Officer	Vente Informative	5,000	$20.00	$100K	92,138
2025-10-28	Jaen Juan C.	President	Vente Informative	19,019	$20.19	$383.94K	1,169,214
2025-10-08	Jarrett Jennifer	Chief Operating Officer	Exercice d'Options (Vente)	37,792	$1.23	$46.39K	130,874
2025-10-06	Jarrett Jennifer	Chief Operating Officer	Exercice d'Options (Vente)	12,500	$1.23	$15.35K	168,666
2025-09-29	Azoy Alexander	Chief Accounting Officer	Vente Informative	2,831	$13.00	$36.8K	27,363
2025-09-05	Azoy Alexander	Chief Accounting Officer	Vente Informative	1,579	$11.88	$18.76K	30,194
2025-06-10	Perlman Andrew J	Director	Attribution de RSU	38,300	$10.02	$383.77K	38,300
2025-06-10	Falberg Kathryn E	Director	Attribution de RSU	38,300	$10.02	$383.77K	38,300
2025-06-10	Kaneko Yasunori	Director	Attribution de RSU	13,300	-	-	33,300
2025-06-10	Machado Patrick	Director	Attribution de RSU	38,300	$10.02	$383.77K	38,300
2025-06-10	Lacey David L.	Director	Attribution de RSU	38,300	$10.02	$383.77K	38,300
2025-06-10	Lambert Nicole	Director	Attribution de RSU	13,300	-	-	37,300
2025-06-10	Ribas Antoni	Director	Attribution de RSU	38,300	$10.02	$383.77K	38,300
2025-02-27	Rosen Terry J	Chief Executive Officer	Achat Informatif	19,800	$10.18	$201.47K	2,554,160
2025-02-27	Kaneko Yasunori	Director	Achat Informatif	20,000	$10.06	$201.2K	28,400
2025-02-18	Gilead Sciences, Inc.	10 Percent Owner	Achat Informatif	1,363,636	$11.00	$15M	31,424,760

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration